Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel

Journal of the American College of Surgeons

Volumn 187, Issue 1, 1998, Pages 9-16

  Lockett, Mark A ^a   Baron, Paul L ^a   O'Brien, Paul H ^a   Elliott, Bruce M ^a   Robison, Jacob G ^a   Maitre, Nathalie ^a   Metcalf, John S ^a   Cole, David J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BIOCHEMICAL MARKER; KERATIN; PROTEIN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA-DIRECTED DNA POLYMERASE; SEVERITY OF ILLNESS INDEX;

EID: 0031813958     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00130-6     Document Type: Article

References (30)

1. Henderson I, Harris J, Kinne D, and Hellman S. Cancer of the Breast. In: DeVita V, Hellman S, Rosenberg S, eds. Cancer, Principles and Practice of Oncology, 3rd Ed. Philadelphia: Lippincott-Raven; 1989:1197-1268.
2. Valagussa P, Bonadonna G, and Veronesi U. Patterns of relapse and survival following radical mastectomy. Cancer 1978; 41:1170-1178.
3. Gardner B, and Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg 1993; 218:270-277.
4. Bettelheim R, Price K, and Goldhirsch A. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990;335:1565-1568.
5. McGurkin M, Cummings M, Walsh M, et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88-95.
6. Taylor CR, and Cote RJ. Immunohistochemical markers of prognostic value in surgical pathology. Histol Histopathol 1997; 12:1039-1055.
7. Mori M, Mimor K, Inove H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase polymerase chain reaction. Cancer Res 1995;55:3417-3420.
8. Noguchi S, Aihara R, Nakamor S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse-transcriptase polymerase chain reaction. Cancer 1994; 74:1595-1600.
9. Noguchi S, Aihara R, Nakamor S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse-transcriptase polymerase chain reaction: comparison between mucl mRNA and keratin-19 mRNA amplification. Am J Pathol 1996;148:649-656.
10. Traweek S, Liu T, and Battifora H. Keratin gene expression in non-epithelial tissues: detection with polymerase chain reaction. Am J Pathol 1993;142:1111-1117.
11. Wu S, Ben-Ezra J, and Colombero A. Detection of micrometastases in breast cancer by the polymerase chain reaction: a feasibility study. Lab Invest 1990;62:109A.
12. Datta Y, Adams P, Drobyski W, et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Immunol 1994;12:475-482.
13. Schoenfeld A, Luqmani Y, Smith D, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994;54:2986-2990.
14. Schoenfeld A, Luqmani Y, Sinnett HD, et al. Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients. Br J Cancer 1996;74:1639-1642.
15. Noguchi S, Aihara R, Motamura K, et al. Histologic characteristics of breast cancers with occult lymph node metastases detected by keratin 19 mRNA reverse transcriptase-polymerase chain reaction. Cancer 1996;78:1235-1240.
16. Watson P, Safneck J, Le K, et al. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 1993;85:902-907.
17. Watson P, Singh R, and Hole A. Influence of c-myc on the progression of human breast cancer. Curr Top Microbiol Immunol 1996;213:267-283.
18. Berns E, Foekens J, van Staveren I, et al. Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment. Gene 1995;159:11-18.
19. Berns E, Klijn J, VanPutten W, et al. C-myc amplification is a better prognostic factor than her2/neu amplification in primary breast cancer. Cancer Res 1992;52:1107-1113.
20. Castro A, Buschbaum P, Nadji M, et al. Tissue immunoreactive prolactin hormone in breast cancer. Research Communications in Chemical Pathology and Pharmacology 1990;29:159-170.
21. Murphy L, Lee-Wing M, Goldenberg G, and Shiu R. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res 1987;47:4160-4164.
22. Shiu R, and Iwasiow B. Prolactin-inducible proteins in human breast cancer cells. J Biol Chem 1985;260:11307-11313.
23. Pagani A, Sapino A, Eusebi V, et al. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch 1994;425:459-465.
24. Clark J, Shiu R, Orr F, and Watson P. Reverse transcription polymerase chain reaction assay for prolactin-inducible protein gene expression to detect human breast cancer micrometastasis. Proc Natl Acad Sci 1996;37:86-87.
25. Hoon D, Wang Y, Dale P, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995;13:2109-2116.
26. Data on file with the National Cancer Data Base (Commission on Cancer of the American College of Surgeons and the American Cancer Society), 1989.
27. Turner RR, Ollila DW, Krasne DL, and Giuliano AE. Histopathologic validation of the sentinel node hypothesis for breast carcinoma. Ann Surg 1997;226:271-278.
28. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadectomy. Ann Surg 1995; 222:394-399.
29. Sedmak DD, Meineke TA, Knechtges DS, et al. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 1989;2:516-520.
30. Pelkey TJ, Frierson HF, and Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996;42:1369-1381.